Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Strand Therapeutics

Request full access

Biotechnology platform intended to create gene therapies powered by synthetic biology

Boston, United StatesFounded 2017Biotech & Life Sciences

About Strand Therapeutics

Strand Therapeutics is a pioneering biotech startup that is developing a unique platform for creating programmable, long-acting mRNA therapeutics. These therapeutics are designed to deliver precise, multi-functional treatments that could potentially cure various diseases. The company's groundbreaking technology allows mRNA to target only diseased cells, thereby increasing the therapeutic window and reducing potential harm to healthy cells. This is achieved by programming logic-based circuits into the mRNA, enabling it to sense different cell types and activate only in the presence of disease.

Strand Therapeutics operates in the biotech market, serving clients in the medical and healthcare sectors. Its primary focus is on developing improved treatment options for cancer and other life-threatening diseases. The company's business model revolves around the development and commercialization of its proprietary mRNA therapeutics. Revenue is generated through the sale of these therapeutics to healthcare providers and institutions.

The company is also open to collaborations and partnerships to expand its programs. As an emerging biotech company, Strand Therapeutics offers vast learning and growth opportunities, including exposure to all aspects of building a company.

Source: Dealroom company data

Strand Therapeutics in the Boston ecosystem

Live from Dealroom

The Strand Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

25 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Playground Global
  • ANRI

Series A14 investors entered at this stage

  • Camford Capital
  • Redmile Group
  • BeOne Medicines
  • FPV Ventures
  • Potentum Partners
  • Eli Lilly
  • Kinnevik
  • Amgen Ventures
  • Alderline Group
  • ICONIQ Capital
  • LG Technology Ventures
  • Gradiant
  • JIC Venture Growth Investments
  • Regeneron Ventures

Series B and later9 investors entered at this stage

  • LG Technology Ventures
  • Massachusetts Institute of Technology
  • Regeneron Ventures
  • ICONIQ Capital
  • JIC Venture Growth Investments
  • Gradiant
  • Alderline Group
  • Kinnevik
  • Amgen Ventures
Employees mapped 121 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Strand Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.